Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39341

DNAJC7 Knockout HCT116 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Large intestine (colon)

  • Disease:

    Carcinoma

DNAJC7 Knockout HCT 116 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population with targeted disruption of the DNAJC7 gene in the MSI-high, MLH1-deficient HCT 116 colorectal carcinoma line. DNAJC7 encodes an Hsp70 co-chaperone that interacts with HSPA8 and HSPA1A, and its loss disrupts protein folding and stress responses. This knockout model enables investigation of chaperone function, protein aggregation, and diphtheria toxin entry in a cancer context. Key applications include western blotting, co-immunoprecipitation, heat shock viability assays, toxin sensitivity testing, and ProteoStat aggregate detection.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HCT 116

    Sex of Donor

    Male

    Age

    Adult

    Derived From Site

    In situ; Colon

    Gene Name

    DNAJC7

    Gene Identifier

    NCBI Gene ID 7266

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

DNAJC7 Knockout HCT 116 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population disrupting the DNAJC7 gene in HCT 116 human colorectal carcinoma cells. This heterogeneous population retains diversity typical of polyclonal pools, avoiding clonal selection bias. Cells harbor targeted gene disruptions that ablate DNAJC7 protein expression, offering a robust loss-of-function model for studying co-chaperone biology. The polyclonal format ensures representation of multiple editing events, yielding an averaged phenotype suitable for bulk biochemical and genetic analyses.

HCT 116 is a colorectal carcinoma epithelial line featuring MSI-high status and MLH1 deficiency, widely used in cancer research for studying DNA repair, tumorigenesis, and drug responses. Its adherent growth and near-diploid genome make it a tractable model for investigating cellular pathways affected in colorectal cancer, including proteostasis networks. Owing to its mismatch repair defect, HCT 116 accumulates mutations and exhibits genetic instability, which provides a relevant background for exploring stress response mechanisms and chaperone dependency in cancer.

DNAJC7 (TPR2) is a tetratricopeptide repeat co-chaperone that directly binds HSPA8 (Hsc70) and HSPA1A (Hsp70), accelerating nucleotide exchange and facilitating substrate transfer into the Hsp70 folding cycle. Under conditions of heat shock or proteotoxic stress, HSF1 transcriptionally activates DNAJC7 expression. Beyond its intracellular chaperone role, DNAJC7 acts as a cell surface receptor for diphtheria toxin, mediating clathrin-dependent endocytosis. In the quality control network, DNAJC7 collaborates with DNAJB1 to deliver clients to Hsp70 and with the E3 ubiquitin ligase STUB1 and the co-chaperone BAG3 to target terminally misfolded proteins for degradation or aggresome sequestration. Consequently, disruption of DNAJC7 leads to impaired Hsp70 client processing, accumulation of aggregation-prone proteins, and altered stress-induced signaling cascades.

In the context of HCT 116 colorectal carcinoma, DNAJC7 ablation is particularly informative because the cell line’s inherent MSI-high and MLH1-null background creates a permissive environment for proteotoxic stress. The interaction between DNAJC7 and STUB1 suggests that the knockout may perturb ubiquitin-dependent proteasomal degradation, while the link to BAG3 indicates potential dysregulation of aggresome formation and autophagy. These disruptions could amplify the sensitivity of HCT 116 cells to heat shock, chemotherapeutic agents, and protein aggregation-inducing conditions, making this model valuable for probing the intersection of protein homeostasis and genomic instability. Furthermore, the polyclonal nature of the knockout allows the study of heterogenous stress adaptation phenotypes within a population, reflecting the cellular diversity found in tumors.

Key applications include confirming DNAJC7 loss by western blotting, monitoring Hsp70 client protein levels, assessing cell viability under heat shock, testing diphtheria toxin sensitivity, and visualizing protein aggregates with ProteoStat immunofluorescence. Co-immunoprecipitation can be used to evaluate interactions between Hsp70 isoforms and other chaperones. RT-qPCR enables quantification of heat shock gene expression changes. The polyclonal format supports pooled CRISPR screens, bulk RNA sequencing, and high-throughput proteostatic assays. For further details and technical support, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)